TDOC · NYSE · Medical - Healthcare Information Services

Teladoc Health (TDOC)

Provides virtual medical care, chronic-condition programs, and online therapy.

$6.23
vs last close−0.13 (−1.97%)
Loading prices…

Teladoc Health, Inc.TDOC
Health Care

Provides virtual care through employer, health-plan, hospital, and health-system relationships, alongside BetterHelp's direct-to-consumer therapy service. The business is mostly U.S.-based and built around access-fee revenue, with consumer marketing efficiency and privacy litigation shaping BetterHelp.

Provides virtual care through Integrated Care, serving employers, health plans, hospitals, and health systems with general medical, chronic-condition, mental-health, expert-opinion, device-enabled, and hospital telehealth services.

Runs BetterHelp as a direct-to-consumer virtual therapy and wellness service with a global therapist network. Revenue is mostly U.S.-based, while past acquisitions added international virtual-care, hospital platform, chronic-care, and specialist-care capabilities.

Executes as a broad access-fee platform rather than a single telemedicine app, combining care navigation, clinician networks, connected devices, and enterprise delivery tools. The business depends on employer and payer relationships, consumer marketing efficiency at BetterHelp, and privacy-related legal proceedings tied to BetterHelp data practices.

Company facts

CEOCharles "Chuck" Divita, III
ListedJul 1, 2015
ExchangeNYSE
HeadquartersNew York, NY
CountryUnited States
Employees5,600
CIK0001477449
ISINUS87918A1051

Market cap$1.15B
EPS (ttm)−$0.9900
P/E (ttm)−6.41
ROE-13.1%
P/B0.8806
P/S0.4634
Dividend yieldDiv yield
Beta1.22vs XLV 0.80

Price target$8.00+26.0%Average of 42 analysts
ConsensusHold27 of 42 analysts
Ratings

Target rangeAs of Sep 22, 2026

Latest analyst notes

DateFirmActionPriorCurrent
Jul 30, 2026JefferiesReiterate
Rating: Target: $10
Rating: HoldTarget: $8
Jul 30, 2026Evercore ISITarget
Target: $6
Target: $7.50
Jul 21, 2026Canaccord GenuityReiterate
Rating: Target: $50
Rating: BuyTarget: $11
Apr 8, 2026Evercore ISITarget
Target: $9
Target: $6
Mar 10, 2026Deutsche BankUpgrade
Rating: HoldTarget: $18
Rating: BuyTarget: $11

Next report
Oct 28, 26
in 35 days
EPS estimate
−$0.23
Revenue estimate
$590.3M
Fiscal quarter
Q3 FY26

EPSReportedEstimate

Feb '25Apr '25Jul '25Oct '25Feb '26Apr '26Jul '26Oct '26
Reported−$0.28−$0.53−$0.19−$0.28−$0.14−$0.36−$0.21Pending
Estimate−$0.23−$0.33−$0.27−$0.26−$0.19−$0.34−$0.25−$0.23
Surprise−21.7%−60.6%+29.6%−7.7%+26.3%−5.5%+15.9%

RevenueReportedEstimate

Feb '25Apr '25Jul '25Oct '25Feb '26Apr '26Jul '26Oct '26
Reported$640.5M$629.4M$631.9M$626.4M$642.3M$613.8M$606.9MPending
Estimate$639.5M$619.2M$622.5M$625.8M$635.3M$610.9M$615.4M$590.3M
Surprise+0.1%+1.6%+1.5%+0.1%+1.1%+0.5%−1.4%
Estimate−$0.23
ReportedDue Oct 28, 2026
Estimate$590.3M
ReportedDue Oct 28, 2026
View details

Debt to equity79.10%
Current ratio83.10%

ProfitabilityRevenueNet incomeNet margin

Q3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26
Revenue$640.5M$640.5M$629.4M$631.9M$626.4M$642.3M$613.8M$606.9M
Net income−$33.3M−$48.4M−$93.0M−$32.7M−$49.5M−$25.1M−$63.8M−$38.9M
Net margin0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%

GrowthOperating income

Q3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26
Operating income−$44.4M−$48.2M−$120.6M−$54.4M−$52.0M−$36.0M−$48.7M−$37.1M
YoY growthLoss narrowedLoss widenedLoss widenedLoss narrowedLoss widenedLoss narrowedLoss narrowedLoss narrowed

Balance sheet, Jun 30, 2026Cash & short-term investments $774.3M · Total debt $1.04B · Total assets $2.76B · Shareholders' equity $1.31B

Revenue
$606.9M
Operating income
−$37.1M
Net income
−$38.9M
View details

No dividends on record.

Institutions85.53%155.40M shares
378 holders · as of Jun 30, 2026
Insiders0.67%1.21M shares
12 holders · as of Sep 14, 2026
Strategic holders5.03%9.14M shares
1 holder · as of Feb 4, 2022
Other8.77%15.93M shares
remainder

181.68M company shares as of Sep 23, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing

Top shareholders13F · 13D/G · Form 4

HolderStakeSharesDate
BlackRock, Inc.Institution
8.93%16.22Mas of Jun 30, 2026
Vanguard Portfolio Management LLCInstitution
6.98%12.69Mas of Jun 30, 2026
Sumitomo Mitsui Trust Holdings, Inc.  (“SMTH”)Strategic
5.03%9.14Mfiled Feb 4, 2022
Nikko Asset Management Americas, Inc.Institution
4.82%8.76Mfiled Feb 14, 2022
Point72 Asset Management, L.P.Institution
4.54%8.24Mas of Jun 30, 2026

Insider tradesForm 4

DateInsiderRoleSharesAvg price
Sep 11, 2026Charles Iii Divitadirector, officer: CHIEF EXECUTIVE OFFICER−17,805$6.10
Sep 3, 2026Fernando M. Rodriguesofficer: President of BetterHelp−9,812$6.51
Sep 2, 2026Fernando M. Rodriguesofficer: President of BetterHelp−5,439$6.30
Sep 2, 2026Charles Iii Divitadirector, officer: CHIEF EXECUTIVE OFFICER−18,327$6.30
Sep 2, 2026Joseph Ronald Catapanoofficer: Chief Accounting Officer−274$6.30
View details

  • Amwell

    Enterprise virtual-care platform for payers and health systems

  • Cigna

    MDLive and Evernorth services compete in virtual and behavioral care

  • LifeStance Health

    Large virtual and in-person outpatient mental-health provider

  • UnitedHealth Group

    Optum competes with virtual, chronic, behavioral, and RPM services

  • Omada Health

    Virtual chronic-care platform for cardiometabolic conditions

  • Hims & Hers Health

    Consumer telehealth platform for wellness, chronic care, and mental health

Compare

CompanyPriceChange
Teladoc Health$6.23−1.97%$1.15B0.5−4.0%
Amwell$13.52+2.31%$224.7M1.0−26.6%
Cigna$272.77−0.35%$72.33B11.38.60.3+6.6%
LifeStance Health$12.12−3.47%$4.87B96.855.53.1+26.1%
UnitedHealth Group$371.04−0.51%$338.69B24.017.40.8+0.4%
Omada Health$20.73−2.97%$1.27B339.269.74.1+43.1%
Hims & Hers Health$29.59−2.76%$6.79B137.62.6+38.3%
Median60.455.51.8+16.3%